AIDX
20/20 Biolabs, Inc. Common Stock
NASDAQ · Healthcare · Medical - Devices · US
$0.59
−3.27%Margins
Gross margin
31.5%
EBITDA margin
-235.1%
EBIT margin
-215.7%
Net margin
-285.0%
FCF margin
-136.6%
-184.0%
Return on equity
-95.0%
Return on assets
-117.9%
Return on invested capital
0.34x
Asset turnover
-$2.8M
Cash from operations
$0.36
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026